JAN (NYSE:JAN) Upgraded to Strong-Buy at Jefferies Financial Group

Jefferies Financial Group upgraded shares of JAN (NYSE:JAN) to a strong-buy rating in a report released on Tuesday morning,Zacks reports.

Several other brokerages have also commented on JAN. Compass Point began coverage on JAN in a report on Wednesday. They set a “neutral” rating and a $37.00 price objective for the company. Cantor Fitzgerald boosted their target price on JAN from $30.00 to $34.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Weiss Ratings began coverage on JAN in a research report on Thursday, August 6th. They set a “hold (c-)” rating on the stock. KeyCorp increased their price target on JAN from $28.00 to $29.00 and gave the company an “overweight” rating in a research note on Wednesday, June 10th. Finally, Scotiabank raised their price target on JAN from $30.00 to $31.00 and gave the stock an “outperform” rating in a report on Wednesday, September 2nd. Two research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $32.31.

JAN Price Performance

NYSE JAN opened at $30.52 on Tuesday. JAN has a 52 week low of $22.76 and a 52 week high of $32.83. The stock’s 50 day moving average price is $30.48.

JAN (NYSE:JAN) last announced its earnings results on Tuesday, August 4th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.23 by ($0.18). The business had revenue of $216.46 million for the quarter, compared to the consensus estimate of $203.32 million. JAN’s quarterly revenue was up 45.4% compared to the same quarter last year. JAN has set its FY 2026 guidance at 0.950-0.980 EPS. Research analysts forecast that JAN will post 0.97 earnings per share for the current fiscal year.

JAN Dividend Announcement

The business also recently declared a monthly dividend, which will be paid on Tuesday, December 29th. Shareholders of record on Friday, December 18th will be issued a $0.0475 dividend. The ex-dividend date of this dividend is Friday, December 18th. This represents a c) dividend on an annualized basis and a dividend yield of 1.9%.

Institutional Investors Weigh In On JAN

Large investors have recently made changes to their positions in the stock. Engineers Gate Manager LP purchased a new position in JAN in the 2nd quarter worth $15,274,000. Wellington Management Group LLP acquired a new stake in JAN during the 2nd quarter worth about $8,739,000. WINTON GROUP Ltd purchased a new stake in JAN during the 2nd quarter valued at about $2,985,000. Readystate Asset Management LP purchased a new stake in JAN during the 2nd quarter valued at about $1,724,000. Finally, Greenland Capital Management LP acquired a new position in shares of JAN in the second quarter valued at about $575,000. 6.27% of the stock is owned by hedge funds and other institutional investors.

Key Stories Impacting JAN

Here are the key news stories impacting JAN this week:

• Positive Sentiment: Jefferies’ upgrade to “strong buy” provides fresh analyst support for JAN and may attract additional buying from investors who follow rating changes. Zacks analyst upgrade report
• Positive Sentiment: Analysts have an average price target of approximately $31.71, modestly above the reference price of $30.52, suggesting some additional upside in the consensus outlook. JAN receives $31.71 average price target
• Neutral Sentiment: JAN’s latest quarter included revenue of $216.46 million, up 45.4% year over year and above estimates, but earnings per share of $0.05 missed consensus by $0.18. Management’s fiscal 2026 EPS guidance remains $0.95–$0.98, broadly consistent with analyst expectations of $0.97.
• Neutral Sentiment: The shares opened near their 50-day moving average of $30.48 and remain below the 52-week high of $32.83, leaving the upgraded rating and upcoming operating results as potential catalysts for further movement.

About JAN

JanOne Inc is a technology and life sciences company focused on addressing the global opioid crisis. The company’s activities include developing and supporting pharmaceutical and other solutions intended to help reduce opioid-related deaths and dependency.

JanOne has also pursued blockchain and financial technology initiatives through its Alt 5 Sigma operations. These activities have included blockchain-based payment, digital asset and financial services solutions designed to help businesses manage transactions and related digital assets.

The company serves markets through its healthcare, technology and financial services initiatives, with an emphasis on solutions that can be applied internationally.